Immunology Activities
Understanding the Complexities of Osteoporosis and Impact on the Health Care System
0290-0000-21-011-H01-P
This is the first module in the 4-part curriculum series and outlines the role of the pharmacist in identifying patients who would most benefit from osteoporosis prevention and screening.
1.00
Current and Emerging Therapies for the Prevention and Treatment of Osteoporosis
0290-0000-21-012-H01-P
This is the second module in the 4-part curriculum series and will review clinical trial data for new and emerging agents and their recommended use as incorporated in the updated 2020 AACE/ACE guidelines.
1.00
Examining the 2020 AACE/ACE Osteoporosis Clinical Guidelines: Featuring Patient Cases
0290-0000-21-013-H01-P
This third module in the 4-part curriculum series will review patient case studies from initial patient screening and diagnosis to initiation of therapy.
1.00
The Role of the Specialty Pharmacist in Osteoporosis Care
0290-0000-21-015-H01-P
This final module of the 4-part curriculum series details the importance of pharmacists and clinicians working in tandem to facilitate access to medications, engage patients in interventions to reduce risk for osteoporosis-related fractures, and optimize overall health outcomes for patients with osteoporosis.
1.00